0000950170-24-028608.txt : 20240308 0000950170-24-028608.hdr.sgml : 20240308 20240308160006 ACCESSION NUMBER: 0000950170-24-028608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levisetti Matteo CENTRAL INDEX KEY: 0001962444 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 24734179 MAIL ADDRESS: STREET 1: C/O CUE BIOPHARMA, INC. STREET 2: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2024-03-06 false 0001645460 Cue Biopharma, Inc. CUE 0001962444 Levisetti Matteo C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 false true false false Chief Medical Officer false Stock Option (right to buy) 1.94 2024-03-06 4 A false 260000 0.0 A 2034-03-05 Common Stock 260000 260000 D This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. /s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact 2024-03-08